Anti-PARK7 antibodies are used in the immunodetection of the protein Parkinsonism associated deglycase. In humans, the canonical protein has a reported length of 189 amino acid residues and a mass of 19.9 kDa. Its subcellular localization is in the cell membrane, nucleus, mitochondria, ER, and cytoplasm. It is reported to be highly expressed in the pancreas, kidney, skeletal muscle, liver, testis and heart. A member of the Peptidase C56 protein family, PARK7 is known to be involved with autophagy pathways and the response to oxidative stress. Synonyms for this target antigen include DJ1, GATD2, HEL-S-67p, Parkinson disease protein 7, Parkinson disease (autosomal recessive, early onset) 7, and DJ-1. PARK7 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Over 160 citations in the literature describe the use of PARK7 antibodies in research. Western Blot is a widely used application for these antibodies. ELISA, Immunofluorescence, and Immunohistochemistry are also common applications.